C
049180
vs
K
KOSPI 200
Over the past 12 months, Cellumed Co Ltd has underperformed KOSPI 200, delivering a return of -21% compared to the KOSPI 200's +111% growth.
Stocks Performance
049180 vs KOSPI 200
Performance Gap
049180 vs KOSPI 200
Performance By Year
049180 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cellumed Co Ltd
Glance View
CELLUMED Co., Ltd. engages in the manufacture and distribution of medical device and biomaterials. The company is headquartered in Seoul, Seoul. The company went IPO on 2002-05-23. The Company’s products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The firm sells its products within domestic market and to overseas markets.
